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Objectives: Because of the immune modulatory effects of vitamin D3 in preeclampsia, we intend to have
a systematic review and meta-analysis on association of both 25-hydroxy vitamin D (25-OHD) level
(parametric approach) and 25-OHD deﬁciency (non-parametric approach) with preeclampsia. As well,
for the parametric part, we used receiver operating characteristic (ROC) curve model.
Materials and methods: We used Web of Science, PubMed and Science Direct data bases through
searching in titles. Google Scholar search engine was used in order to ﬁnd missing papers. Finally 23
studies were imported. Both random and ﬁxed models were reported.
Results: Based on the forest plot, lower levels of 25-OHD were signiﬁcantly associated with risk of pre-
eclampsia (ﬁxed and random P < 0.001). Based on the forest plot, vitamin D deﬁciency (25-OHD < 20 ng/
ml) was signiﬁcantly associated with risk of preeclampsia (ﬁxed P < 0.0001; random P ¼ 0.0029; ﬁxed
OR ¼ 1.33; random OR ¼ 1.54). Based on ROC curve results, we found 2 cutoffs of 10.60 and 20.05 ng/ml.
Conclusion: Women with vitamin D deﬁciency at cutoff 20 ng/ml are more at risk of preeclampsia. This
association can be speciﬁc up to 90% at 10.60 ng/ml cutoff. Treatment of vitamin D deﬁciency is necessary
before pregnancy.
© 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Background
Reproductive immunology is of the conviction that pregnancy is
a kind of transplantation called as semi-allograft. The immune
tolerance induced by natural killer (NK) cells, impedes rejection of
this transplantation. In a successful pregnancy, immune system not
only does not reject embryo, but also protects the transplantation
[1,2]. Other than immune tolerance, adhesive factors [3], angiogenic
factors and hormonal balance play roll in pregnancy maintenance
[4,5]. Of course such other factors are extremely associated immune
system. For example, estrogen/progesterone balance is in near
contact with T-helper1/T-helper2 balance [6]. Another instancehahsavar).
Gynecology. Publishing services b
er (n/a) at Iran University of Medical 
. No other uses without permission. Cwhich is the topic of our present paper is vitamin D3. Other than
nutritional value, this vitamin is an endocrine hormone. As well,
other than being a hormone, vitamin D3 is an immune mediator
[7,8]. Failure of the immune processes mentioned before, results in
blood supplying insufﬁciency of fetus and preeclampsia. Hence
preeclampsia is associated with immune system [1].
Rationale
Regulatory T cells (Treg) are another immune cells involved in
physiology of pregnancy [1]. Tregs (CD4þCD25þ) play role in im-
mune modulation. Proliferation and differentiation of these lym-
phocytes are controlled by forkhead box P3 (FOXP3) gene [9,10].
FOXP3 expression is controlled by transforming growth factor beta
(TGF-b). Other than TGF-b, this gene is affected by vitamin D3.
Therefore, vitamin D receptor (VDR) will be another involved gene
in preeclampsia and other pregnancy complications [11,12]. Ity Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Sciences from ClinicalKey.com by Elsevier on July 14, 2019.
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population [13e15].
Objectives
Because of the immune modulatory effects of vitamin D3 in
preeclampsia, we intend to have a systematic review and meta-
analysis on association of both 25-hydroxy vitamin D (25-OHD)
level (parametric approach) and 25-OHD deﬁciency (non-para-
metric approach) with preeclampsia. As well, for the parametric
part, we are intend to use receiver operating characteristic (ROC)
curve model.
Methods
Study selection
In the present paper we used Web of Science, PubMed and
Science Direct data bases through searching in titles. We found 30,
16 and 25 documents respectively (n ¼ 71). After exclusion of du-
plicates and conference abstracts, 30 papers remained (n ¼ 30).
Then content wise, 17 papers were ﬁnally selected (n ¼ 17). Google
Scholar search engine was used in order to ﬁnd missing papers.
Hereby 5 papers were manually added (n ¼ 23). After data sum-
marizing (Table 1), only studies with complete information of nu-
merical ﬁndings imported for meta-analysis (other papers were
used for qualitative systematic review). Because of high number of
ﬁgures, the ﬂowchart is not shown. PROSPERO web site, was used
for ﬁnding other meta-analyses.
Eligibility criteria
We had content (topic) and numerical criteria. Contentwise,
papers about administration of vitamin D supplements wereTable 1
Summarized information of the imported studies.
Study name Study type Type of PE* Trimester
of 25-OHD
evaluation
Country Pati
num
Bodnar, 2007 NCC NM/All Early/ﬁrst US 49
Baker, 2010 NCC Severe Mid/second US 44
Shand, 2010 Cohort No control Cohort Canada 161
Robinson, 2013 NCC Severe Early/ﬁrst US 40
Scholl, 2013 Cohort NM/All Cohort US 69
Ullah, 2013 Case-control Preeclampsia
Eclampsia
After admission Bangladesh 33
79
Yu, 2013 Case-control Early PE
Late PE
Early/ﬁrst UK 30
60
Bodnar, 2014 Cohort NM/All Cohort US 717
Gernand, 2014 Cohort LDA-CT Cohort US NA
Lechtermann, 2014 Cohort NM/All Cohort Germany 25
Reeves, 2014 Cohort No control Cohort US NA
Rezaei, 2014 Case-control Severe Mid/second Iran 50
Wetta, 2014 NCC NM/All Mid/second UK 89
Achkar, 2015 NCC NM/All Early/ﬁrst Canada 169
Bakacak, 2015 Case-control Preeclampsia
Eclampsia
Mid/second Turkey 83
32
Gidl€of, 2015 NCC NM/All Early/ﬁrst Sweden 37
Singla, 2015 Case-control Mild/severe Mid/second India 74
B€arebring, 2016 Cohort No control First/third Sweden NA
Djekic-Ivankovic,
2016
Case-control NM/All Delivery Serbia 30
Goel, 2016 Case-control NM/All NM India 42
Mirzakhani, 2016 Cohort NM/All Cohort US NA
Hashemipour, 2017 Case-control NM/All NM Iran 74
Zhao, 2017 Cohort Severe Cohort China 139
*PE ¼ preeclampsia; SD ¼ standard deviation; 25-OHD ¼ 25-hyroxy vitamin D; NCC ¼ ne
clinical trial; NA ¼ not applicable.
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(ng/ml) in both groups. For vitamin D deﬁciency our regarded
cutoff point was 20 ng/ml.
Statistical analyses
In order to design our meta-graphs, the software comprehen-
sive meta-analysis version 2 (Biostat, US) was used. We intended to
design two forest plots for both parametric (20-OHD level) and
Odds ratio based (non-parametric approach at cutoff 25-OHD
<20 ng/ml) information. The effect size instructions were
“mean ± SD” and “exposed and unexposed for cases and controls”
respectively. Because of 10 simultaneous studies in each forest plot,
we considered pooled P value of 0.005 instead of 0.05 to control
false signiﬁcance (Bonferroni's correction).
Heterogeneity and publication bias
In order to detect heterogeneity and publication bias, I2 and
funnel plots were used respectively. The forest plots were reported
based on both ﬁxed and random effect models. For odds ratio based
meta-graphs (our non-parametric part of analysis), Yate's correc-
tion was used in order to homogenize the odds ratios from each
side toward OR ¼ 1. This correction procedure was done manually
[16].
Additional analyses
Meta-regression plot was used to show impact of study type in
effect size. For this aim, caseecontrol, nested caseecontrol (NCC)
and cohort studies were ranked 0, 1 and 2 respectively based on
prospectiveness (the level of having prospective nature). In addi-
tion, ROC curve was designed through software GraphPad Prism
version 6 (GraphPad, US) to evaluate medical diagnosis accuracy ofent
ber
Health
number
Patient
25-OHD
(SD) ng/ml
Health
25-OHD
(SD) ng/ml
Patient
25-OHD
<20 ng/ml
Health
25-OHD
<20 ng/ml
Effect size
group for
meta-graph
216 18 (2.4) 21.2 (2.4) NM NM Mean/SD
198 30 (11.2) 39.2 (12) 11 19 Both
28 NM NM 80 17 Excluded
40 16.9 (NM) 33.2 (NM) NM NM Excluded
1072 NM NM 31 360 2 by 2 table
76 23.96 (2.62)
21.56 (2.32)
24.86 (2.04) NM
NM
NM Mean/SD
1000 12.90 (NM)
15.71 (NM)
18.75 (NM) NM NM Excluded
3068 NM NM 432 1749 2 by 2 table
NA NA NA NA NA Excluded
43 18.2 (NM) 33.3 (NM) NM NM Excluded
NA NA NA NA NA Excluded
100 NM NM 40 75 2 by 2 table
177 27.4 (14.4) 28.6 (12.6) NM NM Mean/SD
1975 18.8 (6.4) 20.8 (7.8) 103 909 Both
40 19.3 (4.31)
18.5 (5.47)
23.7 (5.93) NM NM Mean/SD
120 NM NM 14 62 2 by 2 table
100 9.7 (4.94) 14.8 (6.68) NM NM Mean/SD
NA NA NA NA NA Excluded
30 NM NM 29 23 2 by 2 table
50 6.72 (3.81) 9.88 (6.03) 42 46 Both
NA NA NA NA NA Excluded
75 10 (6.4) 11.2 (6.4) 68 65 Both
11012 32.8 (11.7) 37.7 (14.1) 123 8559 Both
sted caseecontrol; NM ¼ not mentioned; E ¼ eclampsia; LDA-CT ¼ low-dose aspirin
cal Sciences from ClinicalKey.com by Elsevier on July 14, 2019.
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25-OHD level of each group of each study, with same weights.
Nmol/lit values were converted to ng/ml through the online source
http://www.vitamindservice.com/node/91.
Results
Selection results
The imported studies were Bodnar, 2007 [14], Baker, 2010 [17],
Shand, 2010 [18], Robinson, 2013 [19], Scholl, 2013 [20], Ullah, 2013Model Study name Statistics for each study
Std diff Standard Lower Upper 
in means error Variance limit limit Z-Valu
Bodnar, 2007 1/333 0/168 0/028 1/003 1/664 7/913
Baker, 2010 0/775 0/172 0/030 0/439 1/112 4/511
Ullah, 2013 0/404 0/210 0/044 -0/008 0/816 1/920
Wetta, 2014 0/091 0/130 0/017 0/164- 0/346 0/698
Achkar , 2015 0/260 0/080 0/006 0/102 0/417 3/237
Bakacak, 2015 0/900 0/201 0/040 0/506 1/293 4/479
Singla, 2015 0/850 0/160 0/026 0/536 1/163 5/311
Goel, 2016 0/615 0/214 0/046 0/195 1/035 2/871
Hashemipour, 2017 0/188 0/164 0/027 0/134- 0/509 1/142
Zhao, 2017 0/348 0/085 0/007 0/181 0/516 4/078
Fixed 0/445 0/042 0/002 0/362 0/527 10/578
Random 0/561 0/116 0/013 0/334 0/788 4/838
Fig. 1. Forest plot of 25-OHD. Favours B shows the protective effec
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Downloaded for Anonymous User (n/a) at Iran University of Medical 
For personal use only. No other uses without permission. C[21], Yu, 2013 [22], Bodnar, 2014 [23], Gernand, 2014 [24], Lech-
termann, 2014 [25], Reeves, 2014 [26], Rezaei, 2014 [27], Wetta,
2014 [28], Achkar, 2015 [29], Bakacak, 2015 [30], Gidl€of, 2015 [31],
Singla, 2015 [32], B€arebring, 2016 [33], Djekic-Ivankovic, 2016 [34],
Goel, 2016 [35], Mirzakhani, 2016 [36], Hashemipour, 2017 [37],
Zhao, 2017 [38]. Summary information of the imported studies are
shown in Table 1. Among the selected papers, 10 of them were
imported for parametric analysis and 10 of themwere imported for
non-parametric analysis. The studies of Ullah et al. and Bakacak
et al. had two subgroups of preeclampsia and eclampsia. We chose
the ﬁrst subgroup for meta-analysis.Std diff in means an d 95% CI
ep-Value
0/000
0/000
0/055
0/485
0/001
0/000
0/000
0/004
0/254
0/000
0/000
0/000
-2/00 -1/00 0/00 1/00 2/00
Favours A Favours B
ts of positive standard difference in means. Fixed I2 ¼ 85.0%.
0/0 0/5 1/0 1/5 2/0
iff in means
 Error by Std diff in means
25-OHD (ﬁxed).
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Based on the forest plot, lower levels of 25-OHD were signiﬁ-
cantly associated with risk of preeclampsia (ﬁxed and random
P < 0.001) (Fig. 1). There was a heterogeneity (ﬁxed I2 ¼ 85.0%) and
there was publication bias based on the funnel plot (Fig. 2).
Non-parametric results
Basedonthe forestplot, vitaminDdeﬁciency (25-OHD<20ng/ml)
was signiﬁcantly associated with risk of preeclampsia (ﬁxedModel Study name Statistics for each stud
Odds Lower Upper 
ratio limit limit Z-Valu
Baker (2010) 2/869 1/243 6/620 2/4
Scholl (2013) 1/647 1/008 2/692 1/9
Bodnar (2014) 1/139 0/965 1/344 1/5
Rezaei (2014) 1/221 0/538 2/769 0/4
Achkar (2015) 1/806 1/310 2/489 3/6
Gidlof (2015) 0/613 0/289 1/299 1/27
Djekic-Ivankovic (2016) 5/255 0/820 33/674 1/7
Goel (2016) 6/247 0/313 124/555 1/2
Hashemipour (2017) 1/506 0/525 4/321 0/7
Zhao (2017) 2/127 1/270 3/563 2/8
Fixed 1/336 1/174 1/520 4/3
Random 1/540 1/159 2/047 2/9
Fig. 3. Forest plot of vitamin D deﬁciency. The odds ratios are Yate's corrected. Fa
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Downloaded for Anonymous User (n/a) at Iran University of Medi
For personal use only. No other uses without permissioP < 0.0001; random P¼ 0.0029; ﬁxed OR¼ 1.33; random OR¼ 1.54)
(Fig. 3). There was a mild heterogeneity (ﬁxed I2 ¼ 57.7%), but there
was no publication bias based on ﬁxed funnel plot (of course random
funnel plot had it) (Figs. 4 and5). Themeta-regressionplot shows that
this effect size would be lower in prospective studies, of course this
ﬁnding was not signiﬁcant (slope P ¼ 0.08) (Fig. 6).
ROC curve results
This model has been used for evaluation of medical diagnosis
accuracy of 25-OHD level in diagnosis/prediction of preeclampsia.y Odds ratio and 95% CI
e p-Value
71 0/0135
90 0/0466
40 0/1236
77 0/6331
08 0/0003
7- 0/2015
51 0/0800
00 0/2302
62 0/4463
67 0/0041
94 0/0000
76 0/0029
0/01 0/1 1 10 100
Favours A Favours B
vours B shows the protective effects of sufﬁcient vitamin D. Fixed I2 ¼ 57.7%.
0/0 0/5 1/0 1/5 2/0
 odds ratio
rd Error by Log odds ratio
t of vitamin D deﬁciency.
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Fig. 5. Random model funnel plot of vitamin D deﬁciency.
Regression of Study type on Log odds ratio
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Fig. 6. Effect of prospectiveness on effect size. Fixed model slope P value ¼ 0.08. (Caseecontrol ¼ 0; NCC ¼ 1; cohort ¼ 2).
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9.79 had up to 100% speciﬁcity (Table 2 and Fig. 7). Of course
this speciﬁcity was in comparison to the control groups, not other
diseases and disorders. As well, this 100% speciﬁcity will not be
clinically occurred because we should regard conﬁdence
intervals.
Discussion
Interpretation of the results
Parametric results
All the studies imported in the forest plot, had protective effect
directions (standard difference in means > 0) (Fig. 1). It shows that
lower levels of vitamin D is associated with risk of preeclampsia in
approximately all populations. Although there was a highDownloaded for Anonymous User (n/a) at Iran University of Medical 
For personal use only. No other uses without permission. Cheterogeneity, but it was not important to us; because this het-
erogeneity depended on ethnicities, FOXP3 and VDR allele genetic
reservoirs, sun exposure condition of the country, season of eval-
uation, etc. of each study. Because of such bias, further interpreta-
tion is not possible.
Non-parametric results
This forest plot is more reliable. The ﬁxed funnel plot showed no
publication bias. It shows that vitamin D deﬁciency at cutoff 20 ng/
ml is deﬁnitely associated with risk of preeclampsia. The pooled
odds ratio was acceptable (of course it was adjusted with Yate's
correction).
ROC curve results
Because of high heterogeneity of the studies in 25-OHD levels,
we preferred to design this curvewithout any weight. The ﬁrst boldSciences from ClinicalKey.com by Elsevier on July 14, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
Fig. 7. ROC curve of 25-OHD level. (Area ¼ 61%).
Table 2
Diagnostic accuracy of serum 25-OHD in preeclampsia.
Cutoff Sensitivity% Speciﬁcity% Likelihood ratio
<8.210 10/00 100/0
<9.790 20/00 100/0
<9.940 20/00 90/00 2/000
<10.60 30/00 90/00 3/000
<13.00 30/00 80/00 1/500
<16.40 30/00 70/00 1/000
<18.40 40/00 70/00 1/333
<19.05 50/00 70/00 1/667
<20.05 60/00 70/00 2/000
<21.00 60/00 60/00 1/500
<22.45 60/00 50/00 1/200
<23.83 60/00 40/00 1/000
<24.41 70/00 40/00 1/167
<26.13 70/00 30/00 1/000
<28.00 80/00 30/00 1/143
<29.30 80/00 20/00 1/000
<31.40 90/00 20/00 1/125
<35.25 100/0 20/00 1/250
<38.45 100/0 10/00 1/111
The chosen cutoffs based on peaks of likelihood ratio are shown in bold.
S. Akbari et al. / Taiwanese Journal of Obstetrics & Gynecology 57 (2018) 241e247246cutoff of Table 2 is more reliable, because the second bold cutoff is
not matched with the non-parametric results (both of them are at
cutoff 20 ng/ml, but the speciﬁcities seem different). Hence at cutoff
20, Fig. 3 is more reliable than the blue-colored part of Table 2.
Summary of evidence
Previously, role of vitamin C and vitamin E had been imported in
a meta-analysis. Based on that, combined supplementation of
vitamin C and vitamin E was not protective for preeclampsia [39].
For vitamin D, a meta-analysis conducted in 2013 suggested that
vitamin D supplementation can reduce risk of preeclampsia [40].
There were 3 ongoing meta-analyses in PROSPERO about vitamin D
and preeclampsia [41e43]. For vitamin D deﬁciency a meta-
analysis was conducted in 2013 showed that vitamin D deﬁciency
increased risk of preeclampsia. There was no parametric analysis in
that study [44].
Epidemiological ﬁndings in Iran
Badfar et al. (2017) performed a meta-analysis on prevalence of
vitamin D deﬁciency in pregnant women. Their meta-regression
plot showed that vitamin deﬁciency was increasing from 1995 to
2016. The prevalence of vitamin D deﬁciency based on cutoffs 10
and 20 ng/ml were respectively 42.42% and 55.84%. Based on ourDownloaded for Anonymous User (n/a) at Iran University of Medi
For personal use only. No other uses without permissioﬁndings, vitamin D supplementation is needed in Iran [45]. A meta-
analysis conducted by Azami et al. (2017) showed that vitamin D
level in Iranian pregnant women was 15.02 ng/ml [46].
Limitations
Different ethnicities and genetic reservoirs of FOXP3 and VDR,
different countries, different types of preeclampsia, different times
and conditions of vitamin D evaluation, and as well different brands
and qualities of kits in different studies. All of these, resulted in the
heterogeneity of the imported studies.
Conclusion
Womenwith vitamin D deﬁciency at cutoff 20 ng/ml aremore at
risk of preeclampsia. This association can be speciﬁc up to 90% at
10.60 ng/ml cutoff. Treatment of vitamin D deﬁciency is necessary
before pregnancy. Cohort studies are suggested for evaluation of
positive predictive value at cutoff 10 in groups of supplement
treated and untreated. Evidence-based ﬁndings should be updated
in text books.
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